American Century Companies’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $204M | Buy |
414,395
+41,929
| +11% | +$22.8M | 0.1% | 184 |
|
|
2025
Q4 | $216M | Buy |
372,466
+98,851
| +36% | +$55.9M | 0.11% | 167 |
|
|
2025
Q3 | $133M | Buy |
273,615
+170,888
| +166% | +$79.5M | 0.07% | 296 |
|
|
2025
Q2 | $41.7M | Sell |
102,727
-1,051
| -1% | -$439K | 0.02% | 754 |
|
|
2025
Q1 | $51.6M | Sell |
103,778
-6,028
| -5% | -$3.26M | 0.03% | 594 |
|
|
2024
Q4 | $57.1M | Sell |
109,806
-6,251
| -5% | -$3.44M | 0.03% | 562 |
|
|
2024
Q3 | $71.8M | Sell |
116,057
-10,239
| -8% | -$6.06M | 0.04% | 453 |
|
|
2024
Q2 | $69.8M | Sell |
126,296
-6,223
| -5% | -$3.57M | 0.04% | 428 |
|
|
2024
Q1 | $77M | Sell |
132,519
-18,056
| -12% | -$10.1M | 0.05% | 401 |
|
|
2023
Q4 | $79.9M | Buy |
150,575
+24,363
| +19% | +$11.8M | 0.05% | 360 |
|
|
2023
Q3 | $63.9M | Sell |
126,212
-4,980
| -4% | -$2.65M | 0.05% | 384 |
|
|
2023
Q2 | $68.4M | Buy |
131,192
+8,005
| +6% | +$4.32M | 0.05% | 355 |
|
|
2023
Q1 | $70.9M | Sell |
123,187
-11,961
| -9% | -$6.74M | 0.06% | 347 |
|
|
2022
Q4 | $74.4M | Sell |
135,148
-41,578
| -24% | -$22M | 0.06% | 329 |
|
|
2022
Q3 | $89.6M | Buy |
176,726
+68,749
| +64% | +$38.5M | 0.08% | 278 |
|
|
2022
Q2 | $58.7M | Buy |
107,977
+13,202
| +14% | +$7.27M | 0.05% | 384 |
|
|
2022
Q1 | $56M | Buy |
94,775
+156
| +0.2% | +$89.6K | 0.04% | 423 |
|
|
2021
Q4 | $63.1M | Sell |
94,619
-9,938
| -10% | -$6.2M | 0.04% | 422 |
|
|
2021
Q3 | $59.7M | Buy |
104,557
+4,716
| +5% | +$2.59M | 0.04% | 412 |
|
|
2021
Q2 | $50.4M | Sell |
99,841
-34,985
| -26% | -$16.5M | 0.03% | 463 |
|
|
2021
Q1 | $61.5M | Buy |
134,826
+43,117
| +47% | +$20.6M | 0.05% | 399 |
|
|
2020
Q4 | $42.7M | Buy |
91,709
+4,337
| +5% | +$2.03M | 0.03% | 430 |
|
|
2020
Q3 | $38.6M | Buy |
87,372
+42,763
| +96% | +$17.7M | 0.03% | 402 |
|
|
2020
Q2 | $16.2M | Buy |
44,609
+42,893
| +2,500% | +$14.4M | 0.02% | 567 |
|
|
2020
Q1 | $487K | Sell |
1,716
-44,112
| -96% | -$13.9M | ﹤0.01% | 1168 |
|
|
2019
Q4 | $14.9M | Sell |
45,828
-276,684
| -86% | -$83.9M | 0.01% | 590 |
|
|
2019
Q3 | $93.9M | Sell |
322,512
-122,839
| -28% | -$35.2M | 0.09% | 247 |
|
|
2019
Q2 | $131M | Buy |
445,351
+2,980
| +0.7% | +$821K | 0.13% | 209 |
|
|
2019
Q1 | $121M | Buy |
442,371
+61,340
| +16% | +$15.3M | 0.12% | 224 |
|
|
2018
Q4 | $85.3M | Buy |
+381,031
| New | +$89.4M | 0.1% | 258 |
|
|
2018
Q1 | – | Sell |
-247,906
| Closed | -$47.1M | – | 1333 |
|
|
2017
Q4 | $47.1M | Buy |
247,906
+172,484
| +229% | +$33M | 0.05% | 387 |
|
|
2017
Q3 | $14.3M | Sell |
75,422
-2,522
| -3% | -$457K | 0.01% | 595 |
|
|
2017
Q2 | $13.6M | Buy |
77,944
+58,421
| +299% | +$9.81M | 0.01% | 606 |
|
|
2017
Q1 | $3M | Sell |
19,523
-266,228
| -93% | -$40.7M | ﹤0.01% | 982 |
|
|
2016
Q4 | $40.3M | Sell |
285,751
-197,989
| -41% | -$29.2M | 0.04% | 405 |
|
|
2016
Q3 | $76.9M | Sell |
483,740
-96,353
| -17% | -$14.8M | 0.08% | 292 |
|
|
2016
Q2 | $85.7M | Buy |
580,093
+12,814
| +2% | +$1.89M | 0.1% | 265 |
|
|
2016
Q1 | $80.3M | Buy |
567,279
+137,750
| +32% | +$18.5M | 0.09% | 288 |
|
|
2015
Q4 | $60.9M | Buy |
+429,529
| New | +$57.3M | 0.07% | 334 |
|
|
2014
Q2 | – | Sell |
-2,545
| Closed | -$306K | – | 1515 |
|
|
2014
Q1 | $306K | Sell |
2,545
-222
| -8% | -$26.4K | ﹤0.01% | 1399 |
|
|
2013
Q4 | $308K | Buy |
2,767
+28
| +1% | +$2.78K | ﹤0.01% | 1389 |
|
|
2013
Q3 | $252K | Sell |
2,739
-40,329
| -94% | -$3.65M | ﹤0.01% | 1420 |
|
|
2013
Q2 | $3.65M | Buy |
+43,068
| New | +$3.59M | ﹤0.01% | 939 |
|
Other funds holding TMO
VCM
American Century Companies's TMO Position: Q1 2026 in Review
American Century Companies increased its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2026, buying an estimated $22.8M and bringing the position to 414,395 shares worth $204M. The position accounts for 0.1% of the portfolio, ranked #184.
American Century Companies first reported a position in TMO in Q2 2013 and has held it in 43 quarters since. The position peaked at $216M in Q4 2025. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- American Century Companies held 414,395 shares of Thermo Fisher Scientific worth $204M as of Q1 2026.
- American Century Companies bought 41,929 Thermo Fisher Scientific shares in Q1 2026, an estimated $22.8M.
- Thermo Fisher Scientific made up 0.1% of American Century Companies's portfolio in Q1 2026, its #184 holding.
- American Century Companies first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 43 quarters since.
- American Century Companies's Thermo Fisher Scientific position peaked at $216M in Q4 2025.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.